Cargando…

Brain Metastasis in Patients with Small Cell Lung Cancer

PURPOSE: To characterize the risk factors for brain metastasis (BM) at presentation and analyze the prognostic factors for patients with small cell lung cancer (SCLC). PATIENTS AND METHODS: Patients were recruited from the SEER database between 2010 and 2016. They were divided into two groups accord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Chu, Yuxin, Song, Qibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710975/ https://www.ncbi.nlm.nih.gov/pubmed/34992434 http://dx.doi.org/10.2147/IJGM.S342009

Ejemplares similares

Risk factors for distant metastasis of patients with primary triple-negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019)

Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
por: Liang, Ping, et al.
Publicado: (2020)

Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer
por: Won, Yong Kyun, et al.
Publicado: (2015)

Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
por: Kim, Sang Young, et al.
Publicado: (2015)

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer
por: Wang, Haiyang, et al.
Publicado: (2018)

Relationship Between Neutrophil-To-Lymphocyte Ratio and Brain Metastasis in Non-Small Cell Lung Cancer Patients
por: Hu, Chunxiao, et al.
Publicado: (2022)

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)

Primary tumor resection benefited the survival of patients with distant metastatic gastric cancer
por: Gao, Yan, et al.
Publicado: (2021)

WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer
por: Li, Zheng, et al.
Publicado: (2022)

The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
por: Xu, Maoyi, et al.
Publicado: (2022)

A novel nomogram predicting cancer-specific survival in small cell lung cancer patients with brain metastasis
por: Rong, Yu-Ting, et al.
Publicado: (2022)

The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma
por: Li, Xiangpan, et al.
Publicado: (2022)

Adjuvant radiotherapy may have significant survival benefits for gastric cancer patients with 1-29 lymph nodes retrieved
por: Wu, Siyi, et al.
Publicado: (2020)

Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis
por: Fan, Ruo-Yue, et al.
Publicado: (2021)

Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs
por: Zeng, Ya, et al.
Publicado: (2023)

Understanding the patient experience and treatment benefits in patients with non–small‐cell lung cancer with brain metastasis
por: Cella, David, et al.
Publicado: (2023)

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
por: Zhang, Qi, et al.
Publicado: (2022)

Preoperative Radiotherapy Is Associated With Significant Survival Benefits for Patients With Gastric Signet Ring Cell Carcinoma: A SEER-Based Approach
por: Gong, Hongyun, et al.
Publicado: (2020)

Anlotinib Combined with Cranial Radiotherapy for Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Retrospectively, Control Study
por: He, Zelai, et al.
Publicado: (2021)

Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated non-small cell lung cancer patients who develop brain metastasis
por: Wang, Wenxian, et al.
Publicado: (2018)

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
por: Baek, Min Young, et al.
Publicado: (2018)

Predicting brain metastasis in early stage non-small cell lung cancer patients by gene expression profiling
por: Kamer, Iris, et al.
Publicado: (2020)

Distribution Of Brain Metastasis From Lung Cancer
por: Wang, Guangyu, et al.
Publicado: (2019)

Serum microRNA-365 suppresses non-small-cell lung cancer metastasis and invasion in patients with bone metastasis of lung cancer
por: Liu, Yanyan, et al.
Publicado: (2020)

Icotinib is as efficacious as gefitinib for brain metastasis of EGFR mutated non-small-cell lung cancer
por: Liu, Kejun, et al.
Publicado: (2020)

Potential monoamine oxidase A inhibitor suppressing paclitaxel‐resistant non‐small cell lung cancer metastasis and growth
por: Yang, Xiaoguang, et al.
Publicado: (2020)

The Efficacy and Safety of Afatinib in Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Meta-Analysis
por: Jin, Hui, et al.
Publicado: (2023)

Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Chu, Xiao, et al.
Publicado: (2019)

Isolated solitary brain metastasis as a relapse of small cell lung cancer
por: SAKURAI, HIROFUMI, et al.
Publicado: (2013)

Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer
por: Sakatani, Toshio, et al.
Publicado: (2019)

Time Interval to Initiation of Whole-Brain Radiation Therapy in Patients With Small Cell Lung Cancer With Brain Metastasis
por: Chevli, Neil, et al.
Publicado: (2021)

Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis
por: Lu, Yunyun, et al.
Publicado: (2016)

Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
por: Zhang, Qun, et al.
Publicado: (2022)

Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis
por: Yoshimura, Akihiro, et al.
Publicado: (2019)

Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasis
por: Byeon, Seonggyu, et al.
Publicado: (2016)

Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer
por: Jung, Gyuseo, et al.
Publicado: (2019)

The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma
por: Xu, Bin, et al.
Publicado: (2021)

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
por: Skakodub, Anna, et al.
Publicado: (2023)

Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis
por: Wang, Feng, et al.
Publicado: (2022)

Phosphorylated-Akt overexpression is associated with a higher risk of brain metastasis in patients with non-small cell lung cancer
por: Jin, Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ao224bi1n98bl2c09r0hn71p8o